Alkeon Capital Management filings

This page lists the SEC filings reported by Alkeon Capital Management.

SEC filings by Alkeon Capital Management (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13ALKEON CAPITAL MANAGEMENT LLCAkero Therapeutics, Inc.3,764,2206.8%EDGAR
SC 13G/A2024-02-13ALKEON CAPITAL MANAGEMENT LLCKeros Therapeutics, Inc.1,498,9075.0%EDGAR
SC 13G/A2024-02-13ALKEON CAPITAL MANAGEMENT LLCOric Pharmaceuticals, Inc.3,604,0966.6%EDGAR
SC 13G/A2024-02-13ALKEON CAPITAL MANAGEMENT LLCRingCentral, Inc.1,528,1571.8%EDGAR
SC 13G/A2023-02-13ALKEON CAPITAL MANAGEMENT LLCAkero Therapeutics, Inc.3,243,9156.9%EDGAR
SC 13G/A2023-02-13ALKEON CAPITAL MANAGEMENT LLCAvaya Holdings Corp.00.0%EDGAR
SC 13G/A2023-02-13ALKEON CAPITAL MANAGEMENT LLCKeros Therapeutics, Inc.1,392,4025.1%EDGAR
SC 13G/A2023-02-13ALKEON CAPITAL MANAGEMENT LLCOric Pharmaceuticals, Inc.2,399,2526.1%EDGAR
SC 13G/A2023-02-13ALKEON CAPITAL MANAGEMENT LLCRingCentral, Inc.4,802,1885.6%EDGAR
SC 13G/A2022-02-14ALKEON CAPITAL MANAGEMENT LLCAkero Therapeutics, Inc.2,479,6717.1%EDGAR
SC 13G2022-02-14ALKEON CAPITAL MANAGEMENT LLCAvaya Holdings Corp.5,898,9416.9%EDGAR
SC 13G2022-02-14ALKEON CAPITAL MANAGEMENT LLCRingCentral, Inc.4,265,0935.2%EDGAR
SC 13G/A2021-02-12ALKEON CAPITAL MANAGEMENT LLCLuckin Coffee Inc.00.0%EDGAR
SC 13G2021-02-11ALKEON CAPITAL MANAGEMENT LLCAkero Therapeutics, Inc.2,287,6306.6%EDGAR
SC 13G/A2020-02-13ALKEON CAPITAL MANAGEMENT LLCSMARTSHEET INC2,889,0962.5%EDGAR
SC 13G/A2020-02-13ALKEON CAPITAL MANAGEMENT LLCHUYA Inc.1,150,0000.7%EDGAR
SC 13G2020-02-13ALKEON CAPITAL MANAGEMENT LLCLuckin Coffee Inc.32,032,4169.6%EDGAR
SC 13G/A2019-02-11ALKEON CAPITAL MANAGEMENT LLCSMARTSHEET INC1,779,0966.2%EDGAR
SC 13G2019-02-11ALKEON CAPITAL MANAGEMENT LLCHUYA Inc.2,368,6665.3%EDGAR
SC 13G2018-07-10ALKEON CAPITAL MANAGEMENT LLCSMARTSHEET INC1,785,00013.3%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.